Abstract 3033: Immuno-PET detection of LAG-3 expressing intratumoral lymphocytes using the zirconium-89 radiolabeled fully human anti-LAG-3 antibody REGN3767 | Citedby Results | Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Abstract 3033: Immuno-PET detection of LAG-3 expressing intratumoral lymphocytes using the zirconium-89 radiolabeled fully human anti-LAG-3 antibody REGN3767

Cancer Res (2018) 78 (13_Supplement): 3033.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma

Peizhe Yuan
Yu Long
Nannan Wei
Yan Wang
Ziyang Zhu
Jinquan Han
Dawei Jiang
Xiaoli Lan
Yongkang Gai

Journal for ImmunoTherapy of Cancer (2024) 12 (7): e009010.

In vivo clinical molecular imaging of T cell activity

Xiaju Cheng
Jiahao Shen
Jingwei Xu
Jinfeng Zhu
Pei Xu
Yong Wang
Mingyuan Gao

Trends in Immunology (2023) 44 (12): 1031.

Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy

Dario Gosmann
Lisa Russelli
Wolfgang A. Weber
Markus Schwaiger
Angela M. Krackhardt
Calogero D’Alessandria

EJNMMI Research (2022) 12 (1)

Positron Emission Tomography Probes for Imaging Cytotoxic Immune Cells

Ala Amgheib
Ruisi Fu
Eric O. Aboagye

Pharmaceutics (2022) 14 (10): 2040.

Imaging cellular immunotherapies and immune cell biomarkers: from preclinical studies to patients

Alessia Volpe
Prasad S Adusumilli
Heiko Schöder
Vladimir Ponomarev

Journal for ImmunoTherapy of Cancer (2022) 10 (9): e004902.

Molecular imaging of immune checkpoints in oncology: Current and future applications

Shushan Ge
Tongtong Jia
Jihui Li
Bin Zhang
Shengming Deng
Shibiao Sang

Cancer Letters (2022) 548: 215896.

Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer Immunotherapy

Louis Lauwerys
Evelien Smits
Tim Van den Wyngaert
Filipe Elvas

Biomedicines (2022) 10 (5): 1074.

Current state and upcoming opportunities for immunoPET biomarkers in lung cancer

Maarten Slebe
Johanna E.E. Pouw
Sayed M.S. Hashemi
C. Willemien Menke-van der Houven van Oordt
Maqsood M. Yaqub
Idris Bahce

Lung Cancer (2022) 169: 84.

Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer

Q. Lecocq
P. Debie
J. Puttemans
R. M. Awad
L. De Beck
T. Ertveldt
Y. De Vlaeminck
C. Goyvaerts
G. Raes
M. Keyaerts
K. Breckpot
N. Devoogdt

EJNMMI Research (2021) 11 (1)

Immune-Checkpoint Inhibitors in B-Cell Lymphoma

Marc Armengol
Juliana Carvalho Santos
Miranda Fernández-Serrano
Núria Profitós-Pelejà
Marcelo Lima Ribeiro
Gaël Roué

Cancers (2021) 13 (2): 214.

Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?

Susanne Lütje
Georg Feldmann
Markus Essler
Peter Brossart
Ralph A. Bundschuh

Journal of Nuclear Medicine (2020) 61 (8): 1137.

Novel Nuclear Medicine Imaging Applications in Immuno-Oncology

Stefano Frega
Alessandro Dal Maso
Giulia Pasello
Lea Cuppari
Laura Bonanno
PierFranco Conte
Laura Evangelista

Cancers (2020) 12 (5): 1303.